Recombinantly produced human factor VIII and IX

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9120873
APP PUB NO 20110262424A1
SERIAL NO

12737815

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A recombinant human factor VIII or IX protein having a human glycosylation pattern but the protein is devoid of N-glycolylneuraminic acid and/or the carbohydrate group Galα-3Gal.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OCTAPHARMA AGSWISS RAHON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Casademunt, Elisabeth München, DE 2 3
Sandberg, Helena Bromma, SE 4 238
Schröder, Carola Neuried, DE 3 25
Stenlund, Peter Bromma, SE 15 84
Tiemeyer, Maya München, DE 3 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 1, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00